Your browser doesn't support javascript.
loading
Deficit of homozygosity among 1.52 million individuals and genetic causes of recessive lethality.
Oddsson, Asmundur; Sulem, Patrick; Sveinbjornsson, Gardar; Arnadottir, Gudny A; Steinthorsdottir, Valgerdur; Halldorsson, Gisli H; Atlason, Bjarni A; Oskarsson, Gudjon R; Helgason, Hannes; Nielsen, Henriette Svarre; Westergaard, David; Karjalainen, Juha M; Katrinardottir, Hildigunnur; Fridriksdottir, Run; Jensson, Brynjar O; Tragante, Vinicius; Ferkingstad, Egil; Jonsson, Hakon; Gudjonsson, Sigurjon A; Beyter, Doruk; Moore, Kristjan H S; Thordardottir, Helga B; Kristmundsdottir, Snaedis; Stefansson, Olafur A; Rantapää-Dahlqvist, Solbritt; Sonderby, Ida Elken; Didriksen, Maria; Stridh, Pernilla; Haavik, Jan; Tryggvadottir, Laufey; Frei, Oleksandr; Walters, G Bragi; Kockum, Ingrid; Hjalgrim, Henrik; Olafsdottir, Thorunn A; Selbaek, Geir; Nyegaard, Mette; Erikstrup, Christian; Brodersen, Thorsten; Saevarsdottir, Saedis; Olsson, Tomas; Nielsen, Kaspar Rene; Haraldsson, Asgeir; Bruun, Mie Topholm; Hansen, Thomas Folkmann; Steingrimsdottir, Thora; Jacobsen, Rikke Louise; Lie, Rolv T; Djurovic, Srdjan; Alfredsson, Lars.
Afiliação
  • Oddsson A; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Sulem P; deCODE genetics/Amgen, Inc., Reykjavik, Iceland. patrick.sulem@decode.is.
  • Sveinbjornsson G; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Arnadottir GA; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Steinthorsdottir V; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Halldorsson GH; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Atlason BA; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Oskarsson GR; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Helgason H; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Nielsen HS; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Westergaard D; Deptartment of Obstetrics and Gynecology, Copenhagen University Hospital, Hvidovre, Denmark.
  • Karjalainen JM; Department of Clinical Medicine, Faculty of Health, University of Copenhagen, Copenhagen, Denmark.
  • Katrinardottir H; Deptartment of Obstetrics and Gynecology, Copenhagen University Hospital, Hvidovre, Denmark.
  • Fridriksdottir R; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Jensson BO; Methods and Analysis, Statistics Denmark, Copenhagen, Denmark.
  • Tragante V; Institute for Molecular Medicine, Finland, University of Helsinki, Helsinki, Finland.
  • Ferkingstad E; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Jonsson H; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Gudjonsson SA; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Beyter D; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Moore KHS; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Thordardottir HB; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Kristmundsdottir S; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Stefansson OA; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Rantapää-Dahlqvist S; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Sonderby IE; Department of Anthropology, University of Iceland, Reykjavik, Iceland.
  • Didriksen M; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Stridh P; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Haavik J; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Tryggvadottir L; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Frei O; Department of Public Health and Clinical Medicine, Rheumatology, Umea University, Umea, Sweden.
  • Walters GB; Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Kockum I; NORMENT Centre, University of Oslo, Oslo, Norway.
  • Hjalgrim H; KG Jebsen Centre for Neurodevelopmental disorders, University of Oslo, Oslo, Norway.
  • Olafsdottir TA; Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Selbaek G; Neuroimmunology Unit, Department of Clinical Neuroscience, Center of Molecular Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Nyegaard M; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Erikstrup C; Bergen Center of Brain Plasticity, Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
  • Brodersen T; Icelandic Cancer Registry, Icelandic Cancer Society, Reykjavik, Iceland.
  • Saevarsdottir S; Faculty of Medicine, BMC, Laeknagardur, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Olsson T; NORMENT Centre, University of Oslo, Oslo, Norway.
  • Nielsen KR; Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Haraldsson A; Centre for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway.
  • Bruun MT; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Hansen TF; Neuroimmunology Unit, Department of Clinical Neuroscience, Center of Molecular Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Steingrimsdottir T; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Jacobsen RL; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  • Lie RT; deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
  • Djurovic S; Norwegian National Centre of Ageing and Health, Vestfold Hospital Trust, Tonsberg, Norway.
  • Alfredsson L; Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway.
Nat Commun ; 14(1): 3453, 2023 06 10.
Article em En | MEDLINE | ID: mdl-37301908
Genotypes causing pregnancy loss and perinatal mortality are depleted among living individuals and are therefore difficult to find. To explore genetic causes of recessive lethality, we searched for sequence variants with deficit of homozygosity among 1.52 million individuals from six European populations. In this study, we identified 25 genes harboring protein-altering sequence variants with a strong deficit of homozygosity (10% or less of predicted homozygotes). Sequence variants in 12 of the genes cause Mendelian disease under a recessive mode of inheritance, two under a dominant mode, but variants in the remaining 11 have not been reported to cause disease. Sequence variants with a strong deficit of homozygosity are over-represented among genes essential for growth of human cell lines and genes orthologous to mouse genes known to affect viability. The function of these genes gives insight into the genetics of intrauterine lethality. We also identified 1077 genes with homozygous predicted loss-of-function genotypes not previously described, bringing the total set of genes completely knocked out in humans to 4785.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Tipo de estudo: Etiology_studies Limite: Animals / Humans Idioma: En Revista: Nat Commun Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Tipo de estudo: Etiology_studies Limite: Animals / Humans Idioma: En Revista: Nat Commun Ano de publicação: 2023 Tipo de documento: Article